Q1 Remicade IBD 2:30 min >15 marks

Remicade is indicated to treatment of severe, active Crohn’s disease, in paediatric patients aged 1 to 5 years, who have not responded to conventional therapy

At least 50% of patients require surgical treatment in the first 10 years of disease and approximately 70–80% will require surgery within their lifetime